Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Exhaled Volatile Organic Compounds as Markers for Medication Use in Asthma

Paul Brinkman, Waqar M. Ahmed, Cristina Gómez, Hugo H. Knobel, Hans Weda, Teunis J. Vink, Tamara M. Nijsen, Craig E. Wheelock, Sven-Erik Dahlen, Paolo Montuschi, Richard G. Knowles, Susanne J. Vijverberg, Anke H. Maitland-van der Zee, Peter J. Sterk, Stephen J. Fowler on behalf of the U-BIOPRED Study Group
European Respiratory Journal 2019; DOI: 10.1183/13993003.00544-2019
Paul Brinkman
1Amsterdam UMC, University of Amsterdam, Department of Respiratory Medicine, Amsterdam Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: p.brinkman@amc.uva.nl
Waqar M. Ahmed
2Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Gómez
3Institute of Environmental Medicine and the Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden
4Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cristina Gómez
Hugo H. Knobel
5Philips Signify, Eindhoven, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Weda
6Philips Research, Eindhoven, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teunis J. Vink
6Philips Research, Eindhoven, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamara M. Nijsen
6Philips Research, Eindhoven, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig E. Wheelock
4Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven-Erik Dahlen
3Institute of Environmental Medicine and the Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Montuschi
7Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard G. Knowles
8Knowles Consulting, Stevenage Bioscience Catalyst, Stevenage, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne J. Vijverberg
1Amsterdam UMC, University of Amsterdam, Department of Respiratory Medicine, Amsterdam Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anke H. Maitland-van der Zee
1Amsterdam UMC, University of Amsterdam, Department of Respiratory Medicine, Amsterdam Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter J. Sterk
1Amsterdam UMC, University of Amsterdam, Department of Respiratory Medicine, Amsterdam Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen J. Fowler
2Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom
9Manchester Academic Health Science Centre, Manchester University Hospitals NHS Foundation Trust, United Kingdom
10See supplementary U-BIOPRED Study Group Contributors list
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen J. Fowler
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/13993003.00544-2019
PubMed 
31515400

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online September 12, 2019.

Article Versions

  • You are currently viewing a previous version of this article (September 12, 2019 - 00:05).
  • View the most recent version of this article
Copyright & Usage 
Copyright ©ERS 2019

Author Information

  1. Paul Brinkman1⇑,
  2. Waqar M. Ahmed2,
  3. Cristina Gómez3,4,
  4. Hugo H. Knobel5,
  5. Hans Weda6,
  6. Teunis J. Vink6,
  7. Tamara M. Nijsen6,
  8. Craig E. Wheelock4,
  9. Sven-Erik Dahlen3,
  10. Paolo Montuschi7,
  11. Richard G. Knowles8,
  12. Susanne J. Vijverberg1,
  13. Anke H. Maitland-van der Zee1,
  14. Peter J. Sterk1 and
  15. Stephen J. Fowler2,9,10
  16. on behalf of the U-BIOPRED Study Group
  1. 1Amsterdam UMC, University of Amsterdam, Department of Respiratory Medicine, Amsterdam Netherlands
  2. 2Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom
  3. 3Institute of Environmental Medicine and the Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden
  4. 4Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
  5. 5Philips Signify, Eindhoven, The Netherlands
  6. 6Philips Research, Eindhoven, The Netherlands
  7. 7Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy
  8. 8Knowles Consulting, Stevenage Bioscience Catalyst, Stevenage, United Kingdom
  9. 9Manchester Academic Health Science Centre, Manchester University Hospitals NHS Foundation Trust, United Kingdom
  10. 10See supplementary U-BIOPRED Study Group Contributors list
  1. Mr P. Brinkman, MSc, Department of Respiratory Medicine, F5-259, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: p.brinkman{at}amc.uva.nl
View Full Text

Funding

  • Innovative Medicines Initiative

    115010

Article usage

Article usage: August 2019 to August 2023

AbstractFullPdf
Aug 2019011
Sep 20194345545
Oct 20193072819
Nov 2019134158
Dec 20191051412
Jan 2020129139
Feb 20205254727
Mar 2020112310866
Apr 20204772519
May 20205081913
Jun 20201421514
Jul 202088116
Aug 20201081310
Sep 202011296
Oct 2020157912
Nov 202095412
Dec 20201111412
Jan 20211232218
Feb 2021751314
Mar 202158127
Apr 2021911410
May 202191149
Jun 2021421717
Jul 202171219
Aug 2021441212
Sep 202175133
Oct 202185428
Nov 202154533
Dec 2021511631
Jan 202213428
Feb 202283229
Mar 2022810436
Apr 202239744
May 202224231
Jun 202265426
Jul 202294327
Aug 202284830
Sep 202284442
Oct 2022144234
Nov 202256833
Dec 202272414
Jan 2023114019
Feb 202394318
Mar 202372518
Apr 202341828
May 2023112533
Jun 2023132326
Jul 202383248
Aug 202334632

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 62 Issue 3 Table of Contents
European Respiratory Journal: 62 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Exhaled Volatile Organic Compounds as Markers for Medication Use in Asthma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Exhaled Volatile Organic Compounds as Markers for Medication Use in Asthma
Paul Brinkman, Waqar M. Ahmed, Cristina Gómez, Hugo H. Knobel, Hans Weda, Teunis J. Vink, Tamara M. Nijsen, Craig E. Wheelock, Sven-Erik Dahlen, Paolo Montuschi, Richard G. Knowles, Susanne J. Vijverberg, Anke H. Maitland-van der Zee, Peter J. Sterk, Stephen J. Fowler
European Respiratory Journal Jan 2019, 1900544; DOI: 10.1183/13993003.00544-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Exhaled Volatile Organic Compounds as Markers for Medication Use in Asthma
Paul Brinkman, Waqar M. Ahmed, Cristina Gómez, Hugo H. Knobel, Hans Weda, Teunis J. Vink, Tamara M. Nijsen, Craig E. Wheelock, Sven-Erik Dahlen, Paolo Montuschi, Richard G. Knowles, Susanne J. Vijverberg, Anke H. Maitland-van der Zee, Peter J. Sterk, Stephen J. Fowler
European Respiratory Journal Jan 2019, 1900544; DOI: 10.1183/13993003.00544-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Prior CV disease and mortality COPD pneumonia patients
  • Factors associated with FEV1 decline in CF
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society